Juxtacortical Chondrosarcoma: Analysis of 52 Cases
Yıl: 2021 Cilt: 54 Sayı: 2 Sayfa Aralığı: 175 - 180 Metin Dili: İngilizce DOI: 10.5505/aot.2021.64497 İndeks Tarihi: 20-12-2021
Juxtacortical Chondrosarcoma: Analysis of 52 Cases
Öz: Introduction: Juxtacortical (surface) chondrosarcoma (JCC) is a very rare subtype of chondrosarcoma, mostly seen in young adults. In this study, we aimed to report demographic data and average survival rates of JCC. Methods:In this study we used the latest version of the Surveillance, Epidemiology and End Results (SEER) database, patients were examined under the titles of gender, age, race / ethnic origin, lesion location in the body, degree of tumor differentiation, applied surgeries and follow-up periods. Descriptive statistics were given as mean ± standard deviation, frequency and percentage. Results: A total of 52 patients were included in the study, of which 16 were female and 36 were male (69%), with a mean age of 41.3 ± 20.0 years (range: 8-84 years). When examined for ethnicity, it was found that it was seen most in white race (84.6%).The most common localization of tumor lesions was the lower extremity long bones (50%).Low grade tumor (45% of all tumors) was the most common tumor differentiation. The mean follow-up was 125,5 months (range 4 to 358 months). Discussion: JCC is a very rare type of chondrosarcoma, and often seen as lower grade compared to other types of chondrosarcoma. It's a little more common in men. It tends to settle on the long bones, most commonly on the lower extremity, especially the femoral diaphysis.
Anahtar Kelime: Jukstakortikal Kondrosarkom: 52 Vakanın Analizi
Öz: Giriş: Jukstakortikal (yüzey) kondrosarkom (JKK), kondrosarkomların daha çok genç erişkinlerde görülen çok nadir bir alt tipidir. Bu çalışmada JKK'ye ait demografik verilerin ve ortalama sağ kalım oranlarının raporlanması amaçlandı. Yöntemler: Sürveyans, Epidemiyoloji ve End Results (SEER) veritabanının en son versiyonu kullanılarak yapılan bu çalışmada, hastalar, cinsiyet, yaş, ırk/etnik köken, lezyonun vücutta yerleşim yeri, tümörün diferansiasyon derecesi, uygulanan cerrahiler ve takip süreleri altbaşlıklarında incelendi. Tanımlayıcı istatistikler ortalama ± standart sapma, sıklık ve yüzde olarak verildi. Bulgular: Çalışmaya toplam 52 hasta dahil edildi, bu hastaların 16'sı kadın 36'i (%69) erkekti ve yaş ortalamaları 41,3±20,0 std (8-84 yaş arası) idi. Etnik köken açısından incelendiğinde en fazla beyaz ırkta (%84,6) görüldüğü saptandı. Tümöral lezyonların en sık görüldüğü lokalizasyon alt ekstremite uzun kemikleri ve ilişkili eklemleri (%50) idi. Tümör diferansiasyonları açısından incelendiğinde en sık düşük dereceli tümörler (tüm tümörlerin %45'i) görüldü. Ortalama takip süresi 125,5 ay (4-358 ay arası) idi. Sonuç: JKK çok nadir bir kondrosarkom türüdür ve sıklıkla diğer kondrosarkom tiplerine göre daha düşük grade'li olarak görülür. Erkeklerde biraz daha sıktır. En sık alt ekstremiteye, özellikle de femur diafizine olmak üzere, uzun kemiklere yerleşim eğilimindedir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1- Herget GW, Uhl M, Opitz OG, Adler CP, Südkamp NP, Knöller S. The many faces of chondrosarcoma of bone, own cases and review of the literature with an emphasis on radiology, pathology and treatment. Acta Chir Orthop Traumatol Cech. 2011; 78(6):501-9
- 2- Weinberg J, Miller TT, Handelsman JE, Kahn LB, Godfried DH, Kenan S. Periosteal chondrosarcoma in a 9-year-old girl with osteochondromatosis. Skeletal Radiol 2005; 34:539–542
- 3- Chaabane S, Bouaziz MC, Drissi C, Abid L, Ladeb MF. Periosteal chondrosarcoma. AJR Am J Roentgenol. 2009 ;192(1):W1-6.
- 4- Papagelopoulos PJ, Galanis EC, Mavrogenis AF, Savvidou OD, Bond JR, Unni KK, Sim FH.. Survivorship analysis in patients with periosteal chondrosarcoma. Clin Orthop Relat Res 2006; 448: 199–207.
- 5- Murphey MD, Walker EA, Wilson AJ, Kransdorf MJ, Temple HT, Gannon FH. From the archives of the AFIP: imaging of primary chondrosarcoma— radiologic–pathologic correlation. RadioGraphics 2003; 23:1245–1278.
- 6- Bertoni F, Boriani S, Laus M, Campanacci M. Periosteal chondrosarcoma and periosteal osteosarcoma: two distinct entities. J Bone Joint Surg Br 1982; 64:370–376
- 7- Aytekin MN, Öztürk R, Amer K. Epidemiological Study of Adamantinoma from US Surveillance, Epidemiology, and End Results Program: III Retrospective Analysis. J Oncol. 2020; 2020: 2809647.
- 8- Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2018 Sub (1975-2016 varying) - Linked To County Attributes - Total U.S., 1969-2017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the November 2018 submission.
- 9- International Classification of Diseases for Oncology. 2018.
- 10- Öztürk R, Arıkan SM, Bulut EK, Kekeç AF, Çelebi F, Güngör BS. Distribution and evaluation of bone and soft tissue tumors operated in a tertiary care center. Acta Orthop Traumatol Turc. 2019; 53(3): 189– 94.
- 11- Efremidou EI, Oikonomou A, Pavlidou E, Drosos G, Koutsopoulos A, Liratzopoulos N. Juxtacortical Clavicular Chondrosarcoma: Diagnostic Dilemmas: Case Report and Review of Literature. Clin Med Insights Oncol. 2013; 7: 13–19.
- 12- Khalil S, Al-Rahawan MG, Al-Rahawan MM. Periosteal mesenchymal chondrosarcoma of the tibia. Skeletal Radiol. 2018; 47(5):605.
- 13- Kumta SM, Griffith JF, Chow LT, Leung PC. Primary juxtacortical chondrosarcoma dedifferentiating after 20 years. Skeletal Radiol. 1998 Oct; 27(10): 569-73.
- 14- Vanel D, De Paolis M, Monti C, Mercuri M, Picci P. Radiological features of 24 periosteal chondrosarcomas. Skeletal Radiol 2001; 30:208–212
- 15- White LM, Sundaram M, et al. Periosteal chondroid tumors: radiologic evaluation with pathologic correlation. AJR 2001; 177:1183– 1188
| APA | öztürk r, Amer K, Bulut E, Aytekin M (2021). Juxtacortical Chondrosarcoma: Analysis of 52 Cases. , 175 - 180. 10.5505/aot.2021.64497 |
| Chicago | öztürk recep,Amer Kamil,Bulut Emin kursat,Aytekin Mahmut Nedim Juxtacortical Chondrosarcoma: Analysis of 52 Cases. (2021): 175 - 180. 10.5505/aot.2021.64497 |
| MLA | öztürk recep,Amer Kamil,Bulut Emin kursat,Aytekin Mahmut Nedim Juxtacortical Chondrosarcoma: Analysis of 52 Cases. , 2021, ss.175 - 180. 10.5505/aot.2021.64497 |
| AMA | öztürk r,Amer K,Bulut E,Aytekin M Juxtacortical Chondrosarcoma: Analysis of 52 Cases. . 2021; 175 - 180. 10.5505/aot.2021.64497 |
| Vancouver | öztürk r,Amer K,Bulut E,Aytekin M Juxtacortical Chondrosarcoma: Analysis of 52 Cases. . 2021; 175 - 180. 10.5505/aot.2021.64497 |
| IEEE | öztürk r,Amer K,Bulut E,Aytekin M "Juxtacortical Chondrosarcoma: Analysis of 52 Cases." , ss.175 - 180, 2021. 10.5505/aot.2021.64497 |
| ISNAD | öztürk, recep vd. "Juxtacortical Chondrosarcoma: Analysis of 52 Cases". (2021), 175-180. https://doi.org/10.5505/aot.2021.64497 |
| APA | öztürk r, Amer K, Bulut E, Aytekin M (2021). Juxtacortical Chondrosarcoma: Analysis of 52 Cases. ACTA ONCOLOGICA TURCICA, 54(2), 175 - 180. 10.5505/aot.2021.64497 |
| Chicago | öztürk recep,Amer Kamil,Bulut Emin kursat,Aytekin Mahmut Nedim Juxtacortical Chondrosarcoma: Analysis of 52 Cases. ACTA ONCOLOGICA TURCICA 54, no.2 (2021): 175 - 180. 10.5505/aot.2021.64497 |
| MLA | öztürk recep,Amer Kamil,Bulut Emin kursat,Aytekin Mahmut Nedim Juxtacortical Chondrosarcoma: Analysis of 52 Cases. ACTA ONCOLOGICA TURCICA, vol.54, no.2, 2021, ss.175 - 180. 10.5505/aot.2021.64497 |
| AMA | öztürk r,Amer K,Bulut E,Aytekin M Juxtacortical Chondrosarcoma: Analysis of 52 Cases. ACTA ONCOLOGICA TURCICA. 2021; 54(2): 175 - 180. 10.5505/aot.2021.64497 |
| Vancouver | öztürk r,Amer K,Bulut E,Aytekin M Juxtacortical Chondrosarcoma: Analysis of 52 Cases. ACTA ONCOLOGICA TURCICA. 2021; 54(2): 175 - 180. 10.5505/aot.2021.64497 |
| IEEE | öztürk r,Amer K,Bulut E,Aytekin M "Juxtacortical Chondrosarcoma: Analysis of 52 Cases." ACTA ONCOLOGICA TURCICA, 54, ss.175 - 180, 2021. 10.5505/aot.2021.64497 |
| ISNAD | öztürk, recep vd. "Juxtacortical Chondrosarcoma: Analysis of 52 Cases". ACTA ONCOLOGICA TURCICA 54/2 (2021), 175-180. https://doi.org/10.5505/aot.2021.64497 |
